|
Samples(cell line) | Exposure Devices | Speed (RPM1) | Exposure time | Major result | Ref. |
|
Colorectal cancer | | | | | |
|
MIP-101 | r-μg / Two Spaceflights | — | 10 d and 12 d | Proliferation and apoptosis decreased | [19] |
DLD1,HCT116,SW620 | s-μg / RCCS-HARV | 10 | 48 h | Cell clumping and apoptosis increased | [20] |
DLD1 | s-μg / RCCS-HARV | 27 | 72 h | Cell cycle arrested | [21] |
|
Lung cancer | | | | | |
|
A549,H1703 | s-μg / 3D clinostat system | 5 | 36 h | Proliferation rates decreased in H1703; while migration ability increased in both | [22] |
H460 | s-μg / RPM2 | — | 48 h | Apoptosis increased | [23] |
A549 | s-μg / MG-3 clinostat system | 30 | 72 h | Metastatic potential,proliferation,while migration and invasion reduced | [24] |
|
Throid cancer | | | | | |
|
ML-1 | s-μg / RPM2 | 10 | 72 h | IF, ECM and apoptosis increased | [25] |
ML-1 | r-μg / PFC | — | 22 s | F-actin/cytokeratin cytoskeleton altered, no signs of apoptosis | [26] |
ML-1 | s-μg / RPM2 | — | 72 h | 3D spheroid formation, ECM increased | [27] |
ML-1 | s-μg / RPM2 | 10 | 7 d | 3D spheroid formation | [28] |
ML-1 | s-μg / RPM2 | 10 | 11 d | actin and tubulin altered | [29] |
UCLA RO82-W-1 | s-μg / RPM2 | 10 | 24 h | 3D spheroid formation, ECM increased | [30] |
UCLA RO82-W-1 | s-μg / RPM2 | 10 | 7 d | 3D spheroid formation | [28] |
FTC-133 | r-μg / Shenzhou-8 space mission | — | 10 d | 3D spheroid formation | [31] |
FTC-133 | r-μg / International Space Station | — | 12 d | Enhanced production of proteins related to the ECM | [32] |
FTC-133 | r-μg / TEXUS-52 | — | 369 s | Significant alterations of the cytoskeleton | [33] |
FTC-133 | s-μg / 2D clinostat | 60 | 3 d | 3D spheroid formation, CAV1 and CTGF decreased in spheroids | [34] |
FTC-133 | s-μg / RPM2 | 10 | 3 d | 3D spheroid formation, CAV1 and CTGF decreased in spheroids | [34] |
FTC-133 | s-μg / RPM2 | 10 | 24 h | 3D spheroid formation, apoptosis increased, CTGF decreased in spheroids | [35] |
ONCO-DG1 | s-μg / Clinorotation | 10 | 24 h | Cell clumping and apoptosis increased | [36] |
|
Breast cancer | | | | | |
|
MCF-7 | r-μg / Spaceflight | — | 48 h | Cytokeratin network were looser, cell cycle arrested and proliferation decreased | [37] |
MCF-7 | r-μg / Spaceflight | — | 48 h | Cytoskeleton changes, cell cycle prolonged | [38] |
MCF-7 | s-μg / RPM2 | 12.5 | 24 h | 3D spheroid formation, apoptosis-related proteins increased | [39] |
MDA-MB-231,MCF-7 | s-μg / RCCS | 20-25 | 5 d | Cyclin D1 decreased | [40] |
MDA-MB-231 | s-μg / RPM2 | 10 | 72 h | G2/M inibited and cyclin D1 decreased | [41] |
MCF-7 | s-μg / MG-6C clinostat system | 30 | 72 h | Cell invasion and migration decreased, | [42] |
MCF-7 | s-μg / RPM2 | — | 48 h | Proliferation decreased, while apoptosis-related proteins increased | [43] |
|
Other cancer | | | | | |
|
SGC-7901 gastric cancer | s-μg / MG-3 clinostat system | 30 | 72 h | Proliferation and apoptosis decreased | [44] |
U251 glioma | s-μg / 2D clinostat system | — | 72 h | Proliferation and apoptosis decreased | [45] |
Multiple human tumor | s-μg / RCCS-HARV | 25 | 7 d | Spheroid formation | [46] |
|